1.1616
+0.0632
+(5.75%)
At close: January 31 at 8:00:44 AM GMT+1
Key Executives
Key Executives Information Not Available
Sangamo Therapeutics Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Sangamo Therapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 11, 2025 at 12:30 PM UTC - March 17, 2025 at 12:30 PM UTC
Sangamo Therapeutics Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
ZVA.MU Cellectis SA
1.5500
+3.20%
BLE.MU bluebird bio, Inc.
0.0000
0.00%
0QF.F Moderna, Inc.
38.32
-5.36%
BLUE bluebird bio, Inc.
7.75
-2.02%
ARGX argenx SE
655.13
-1.58%
BCTX BriaCell Therapeutics Corp.
5.02
-9.87%
CKPT Checkpoint Therapeutics, Inc.
2.8400
0.00%
DNA Ginkgo Bioworks Holdings, Inc.
13.36
-3.95%
MNMD Mind Medicine (MindMed) Inc.
6.79
-4.77%
OCGN Ocugen, Inc.
0.7274
-5.43%